The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.

The global Immunology Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunology Drug in various end use industries. The expanding demands from the Hospitals, Clinics and Cancer Research Centers and Institutes,, are propelling Immunology Drug market. Monoclonal Antibodies (mAb), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibody Drug Conjugates segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunology Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Immunology Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Immunology Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunology Drug sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Immunology Drug covered in this report include Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech and F. Hoffmann-La Roche Ltd., etc.

The global Immunology Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Abbott Laboratories

Active Biotech

Eli Lilly and Company

Autoimmune Inc.

Pfizer

GlaxoSmithKline plc

Seattle Genetics

Genentech

F. Hoffmann-La Roche Ltd.

Eisai Co.

Bayer AG

Sanofi Aventis LLC.

Scope of Immunology Drug - Market Report

Report Metric	Details
Report Name	Immunology Drug - Market
CAGR	5%
Global Immunology Drug market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunology Drug market, Segment by Type:	Monoclonal Antibodies (mAb) Antibody Drug Conjugates Immunosuppressive medication Others
Global Immunology Drug market, by Application	Hospitals Clinics Cancer Research Centers and Institutes
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Immunology Drug - Market report?

Ans: The Applications covered in the Immunology Drug - Market report are Hospitals, Clinics, Cancer Research Centers and Institutes

What are the Type segmentation covered in the Immunology Drug - Market report?

Ans: The Types covered in the Immunology Drug - Market report are Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Immunosuppressive medication, Others

1 Immunology Drug Market Overview

1.1 Immunology Drug Product Overview

1.2 Immunology Drug Market Segment by Type

1.2.1 Monoclonal Antibodies (mAb)

1.2.2 Antibody Drug Conjugates

1.2.3 Immunosuppressive medication

1.2.4 Others

1.3 Global Immunology Drug Market Size by Type

1.3.1 Global Immunology Drug Market Size Overview by Type (2018-2029)

1.3.2 Global Immunology Drug Historic Market Size Review by Type (2018-2023)

1.3.3 Global Immunology Drug Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Immunology Drug Sales Breakdown by Type (2018-2023)

1.4.2 Europe Immunology Drug Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Immunology Drug Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Immunology Drug Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Immunology Drug Sales Breakdown by Type (2018-2023)

2 Global Immunology Drug Market Competition by Company

2.1 Global Top Players by Immunology Drug Sales (2018-2023)

2.2 Global Top Players by Immunology Drug Revenue (2018-2023)

2.3 Global Top Players by Immunology Drug Price (2018-2023)

2.4 Global Top Manufacturers Immunology Drug Manufacturing Base Distribution, Sales Area, Product Type

2.5 Immunology Drug Market Competitive Situation and Trends

2.5.1 Immunology Drug Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Immunology Drug Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunology Drug as of 2022)

2.7 Date of Key Manufacturers Enter into Immunology Drug Market

2.8 Key Manufacturers Immunology Drug Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Immunology Drug Status and Outlook by Region

3.1 Global Immunology Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Immunology Drug Historic Market Size by Region

3.2.1 Global Immunology Drug Sales in Volume by Region (2018-2023)

3.2.2 Global Immunology Drug Sales in Value by Region (2018-2023)

3.2.3 Global Immunology Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Immunology Drug Forecasted Market Size by Region

3.3.1 Global Immunology Drug Sales in Volume by Region (2024-2029)

3.3.2 Global Immunology Drug Sales in Value by Region (2024-2029)

3.3.3 Global Immunology Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Immunology Drug by Application

4.1 Immunology Drug Market Segment by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Cancer Research Centers and Institutes

4.2 Global Immunology Drug Market Size by Application

4.2.1 Global Immunology Drug Market Size Overview by Application (2018-2029)

4.2.2 Global Immunology Drug Historic Market Size Review by Application (2018-2023)

4.2.3 Global Immunology Drug Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Immunology Drug Sales Breakdown by Application (2018-2023)

4.3.2 Europe Immunology Drug Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Immunology Drug Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Immunology Drug Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Immunology Drug Sales Breakdown by Application (2018-2023)

5 North America Immunology Drug by Country

5.1 North America Immunology Drug Historic Market Size by Country

5.1.1 North America Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Immunology Drug Sales in Volume by Country (2018-2023)

5.1.3 North America Immunology Drug Sales in Value by Country (2018-2023)

5.2 North America Immunology Drug Forecasted Market Size by Country

5.2.1 North America Immunology Drug Sales in Volume by Country (2024-2029)

5.2.2 North America Immunology Drug Sales in Value by Country (2024-2029)

6 Europe Immunology Drug by Country

6.1 Europe Immunology Drug Historic Market Size by Country

6.1.1 Europe Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Immunology Drug Sales in Volume by Country (2018-2023)

6.1.3 Europe Immunology Drug Sales in Value by Country (2018-2023)

6.2 Europe Immunology Drug Forecasted Market Size by Country

6.2.1 Europe Immunology Drug Sales in Volume by Country (2024-2029)

6.2.2 Europe Immunology Drug Sales in Value by Country (2024-2029)

7 Asia-Pacific Immunology Drug by Region

7.1 Asia-Pacific Immunology Drug Historic Market Size by Region

7.1.1 Asia-Pacific Immunology Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Immunology Drug Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Immunology Drug Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Immunology Drug Forecasted Market Size by Region

7.2.1 Asia-Pacific Immunology Drug Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Immunology Drug Sales in Value by Region (2024-2029)

8 Latin America Immunology Drug by Country

8.1 Latin America Immunology Drug Historic Market Size by Country

8.1.1 Latin America Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Immunology Drug Sales in Volume by Country (2018-2023)

8.1.3 Latin America Immunology Drug Sales in Value by Country (2018-2023)

8.2 Latin America Immunology Drug Forecasted Market Size by Country

8.2.1 Latin America Immunology Drug Sales in Volume by Country (2024-2029)

8.2.2 Latin America Immunology Drug Sales in Value by Country (2024-2029)

9 Middle East and Africa Immunology Drug by Country

9.1 Middle East and Africa Immunology Drug Historic Market Size by Country

9.1.1 Middle East and Africa Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Immunology Drug Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Immunology Drug Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Immunology Drug Forecasted Market Size by Country

9.2.1 Middle East and Africa Immunology Drug Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Immunology Drug Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Abbott Laboratories

10.1.1 Abbott Laboratories Company Information

10.1.2 Abbott Laboratories Introduction and Business Overview

10.1.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Abbott Laboratories Immunology Drug Products Offered

10.1.5 Abbott Laboratories Recent Development

10.2 Active Biotech

10.2.1 Active Biotech Company Information

10.2.2 Active Biotech Introduction and Business Overview

10.2.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Active Biotech Immunology Drug Products Offered

10.2.5 Active Biotech Recent Development

10.3 Eli Lilly and Company

10.3.1 Eli Lilly and Company Company Information

10.3.2 Eli Lilly and Company Introduction and Business Overview

10.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Eli Lilly and Company Immunology Drug Products Offered

10.3.5 Eli Lilly and Company Recent Development

10.4 Autoimmune Inc.

10.4.1 Autoimmune Inc. Company Information

10.4.2 Autoimmune Inc. Introduction and Business Overview

10.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Autoimmune Inc. Immunology Drug Products Offered

10.4.5 Autoimmune Inc. Recent Development

10.5 Pfizer

10.5.1 Pfizer Company Information

10.5.2 Pfizer Introduction and Business Overview

10.5.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Pfizer Immunology Drug Products Offered

10.5.5 Pfizer Recent Development

10.6 GlaxoSmithKline plc

10.6.1 GlaxoSmithKline plc Company Information

10.6.2 GlaxoSmithKline plc Introduction and Business Overview

10.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.6.4 GlaxoSmithKline plc Immunology Drug Products Offered

10.6.5 GlaxoSmithKline plc Recent Development

10.7 Seattle Genetics

10.7.1 Seattle Genetics Company Information

10.7.2 Seattle Genetics Introduction and Business Overview

10.7.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Seattle Genetics Immunology Drug Products Offered

10.7.5 Seattle Genetics Recent Development

10.8 Genentech

10.8.1 Genentech Company Information

10.8.2 Genentech Introduction and Business Overview

10.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Genentech Immunology Drug Products Offered

10.8.5 Genentech Recent Development

10.9 F. Hoffmann-La Roche Ltd.

10.9.1 F. Hoffmann-La Roche Ltd. Company Information

10.9.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview

10.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered

10.9.5 F. Hoffmann-La Roche Ltd. Recent Development

10.10 Eisai Co.

10.10.1 Eisai Co. Company Information

10.10.2 Eisai Co. Introduction and Business Overview

10.10.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Eisai Co. Immunology Drug Products Offered

10.10.5 Eisai Co. Recent Development

10.11 Bayer AG

10.11.1 Bayer AG Company Information

10.11.2 Bayer AG Introduction and Business Overview

10.11.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Bayer AG Immunology Drug Products Offered

10.11.5 Bayer AG Recent Development

10.12 Sanofi Aventis LLC.

10.12.1 Sanofi Aventis LLC. Company Information

10.12.2 Sanofi Aventis LLC. Introduction and Business Overview

10.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)

10.12.4 Sanofi Aventis LLC. Immunology Drug Products Offered

10.12.5 Sanofi Aventis LLC. Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Immunology Drug Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Immunology Drug Industrial Chain Analysis

11.4 Immunology Drug Market Dynamics

11.4.1 Immunology Drug Industry Trends

11.4.2 Immunology Drug Market Drivers

11.4.3 Immunology Drug Market Challenges

11.4.4 Immunology Drug Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Immunology Drug Distributors

12.3 Immunology Drug Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Active Biotech

Eli Lilly and Company

F Hoffmann La Roche Ltd

Eisai Co Ltd

Bayer

Sanofi-Aventis LLC

List of Tables

Table 1. Major Company of Monoclonal Antibodies (mAb)

Table 2. Major Company of Antibody Drug Conjugates

Table 3. Major Company of Immunosuppressive medication

Table 4. Major Company of Others

Table 5. Global Immunology Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 6. Global Immunology Drug Sales by Type (2018-2023) & (K Units)

Table 7. Global Immunology Drug Sales Market Share in Volume by Type (2018-2023)

Table 8. Global Immunology Drug Sales by Type (2018-2023) & (US& Million)

Table 9. Global Immunology Drug Market Share in Value by Type (2018-2023)

Table 10. Global Immunology Drug Price by Type (2018-2023) & (USD/Unit)

Table 11. Global Immunology Drug Sales by Type (2024-2029) & (K Units)

Table 12. Global Immunology Drug Sales Market Share in Volume by Type (2024-2029)

Table 13. Global Immunology Drug Sales by Type (2024-2029) & (US$ Million)

Table 14. Global Immunology Drug Sales Market Share in Value by Type (2024-2029)

Table 15. Global Immunology Drug Price by Type (2024-2029) & (USD/Unit)

Table 16. North America Immunology Drug Sales by Type (2018-2023) & (K Units)

Table 17. North America Immunology Drug Sales by Type (2018-2023) & (US$ Million)

Table 18. Europe Immunology Drug Sales (K Units) by Type (2018-2023)

Table 19. Europe Immunology Drug Sales by Type (2018-2023) & (US$ Million)

Table 20. Asia-Pacific Immunology Drug Sales (K Units) by Type (2018-2023)

Table 21. Asia-Pacific Immunology Drug Sales by Type (2018-2023) & (US$ Million)

Table 22. Latin America Immunology Drug Sales (K Units) by Type (2018-2023)

Table 23. Latin America Immunology Drug Sales by Type (2018-2023) & (US$ Million)

Table 24. Middle East and Africa Immunology Drug Sales (K Units) by Type (2018-2023)

Table 25. Middle East and Africa Immunology Drug Sales by Type (2018-2023) & (US$ Million)

Table 26. Global Immunology Drug Sales by Company (2018-2023) & (K Units)

Table 27. Global Immunology Drug Sales Share by Company (2018-2023)

Table 28. Global Immunology Drug Revenue by Company (2018-2023) & (US$ Million)

Table 29. Global Immunology Drug Revenue Share by Company (2018-2023)

Table 30. Global Market Immunology Drug Price by Company (2018-2023) & (USD/Unit)

Table 31. Global Immunology Drug Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 32. Global Immunology Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunology Drug as of 2022)

Table 34. Date of Key Manufacturers Enter into Immunology Drug Market

Table 35. Key Manufacturers Immunology Drug Product Type

Table 36. Mergers & Acquisitions, Expansion Plans

Table 37. Global Immunology Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 38. Global Immunology Drug Sales by Region (2018-2023) & (K Units)

Table 39. Global Immunology Drug Sales Market Share in Volume by Region (2018-2023)

Table 40. Global Immunology Drug Sales by Region (2018-2023) & (US$ Million)

Table 41. Global Immunology Drug Sales Market Share in Value by Region (2018-2023)

Table 42. Global Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 43. Global Immunology Drug Sales by Region (2024-2029) & (K Units)

Table 44. Global Immunology Drug Sales Market Share in Volume by Region (2024-2029)

Table 45. Global Immunology Drug Sales by Region (2024-2029) & (US$ Million)

Table 46. Global Immunology Drug Sales Market Share in Value by Region (2024-2029)

Table 47. Global Immunology Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

Table 48. Global Immunology Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 49. Global Immunology Drug Sales by Application (2018-2023) & (K Units)

Table 50. Global Immunology Drug Sales Market Share in Volume by Application (2018-2023)

Table 51. Global Immunology Drug Sales by Application (2018-2023) & (US$ Million)

Table 52. Global Immunology Drug Sales Market Share in Value by Application (2018-2023)

Table 53. Global Immunology Drug Price by Application (2018-2023) & (USD/Unit)

Table 54. Global Immunology Drug Sales by Application (2024-2029) & (K Units)

Table 55. Global Immunology Drug Sales Market Share in Volume by Application (2024-2029)

Table 56. Global Immunology Drug Sales by Application (2024-2029) & (US$ Million)

Table 57. Global Immunology Drug Sales Market Share in Value by Application (2024-2029)

Table 58. Global Immunology Drug Price by Application (2024-2029) & (USD/Unit)

Table 59. North America Immunology Drug Sales by Application (2018-2023) (K Units)

Table 60. North America Immunology Drug Sales by Application (2018-2023) & (US$ Million)

Table 61. Europe Immunology Drug Sales by Application (2018-2023) (K Units)

Table 62. Europe Immunology Drug Sales by Application (2018-2023) & (US$ Million)

Table 63. Asia-Pacific Immunology Drug Sales by Application (2018-2023) (K Units)

Table 64. Asia-Pacific Immunology Drug Sales by Application (2018-2023) & (US$ Million)

Table 65. Latin America Immunology Drug Sales by Application (2018-2023) (K Units)

Table 66. Latin America Immunology Drug Sales by Application (2018-2023) & (US$ Million)

Table 67. Middle East and Africa Immunology Drug Sales by Application (2018-2023) (K Units)

Table 68. Middle East and Africa Immunology Drug Sales by Application (2018-2023) & (US$ Million)

Table 69. North America Immunology Drug Sales by Country (2018-2023) & (K Units)

Table 70. North America Immunology Drug Sales Market Share in Volume by Country (2018-2023)

Table 71. North America Immunology Drug Sales by Country (2018-2023) & (US$ Million)

Table 72. North America Immunology Drug Sales Market Share in Value by Country (2018-2023)

Table 73. North America Immunology Drug Sales by Country (2024-2029) & (K Units)

Table 74. North America Immunology Drug Sales Market Share in Volume by Country (2024-2029)

Table 75. North America Immunology Drug Sales by Country (2024-2029) & (US$ Million)

Table 76. North America Immunology Drug Sales Market Share in Value by Country (2024-2029)

Table 77. Europe Immunology Drug Sales by Country (2018-2023) & (K Units)

Table 78. Europe Immunology Drug Sales Market Share in Volume by Country (2018-2023)

Table 79. Europe Immunology Drug Sales by Country (2018-2023) & (US$ Million)

Table 80. Europe Immunology Drug Sales Market Share in Value by Country (2018-2023)

Table 81. Europe Immunology Drug Sales by Country (2024-2029) & (K Units)

Table 82. Europe Immunology Drug Sales Market Share in Volume by Country (2024-2029)

Table 83. Europe Immunology Drug Sales by Country (2024-2029) & (US$ Million)

Table 84. Europe Immunology Drug Sales Market Share in Value by Country (2024-2029)

Table 85. Asia-Pacific Immunology Drug Sales by Region (2018-2023) & (K Units)

Table 86. Asia-Pacific Immunology Drug Sales Market Share in Volume by Region (2018-2023)

Table 87. Asia-Pacific Immunology Drug Sales by Region (2018-2023) & (US$ Million)

Table 88. Asia-Pacific Immunology Drug Sales Market Share in Value by Region (2018-2023)

Table 89. Asia-Pacific Immunology Drug Sales by Region (2024-2029) & (K Units)

Table 90. Asia-Pacific Immunology Drug Sales Market Share in Volume by Region (2024-2029)

Table 91. Asia-Pacific Immunology Drug Sales by Region (2024-2029) & (US$ Million)

Table 92. Asia-Pacific Immunology Drug Sales Market Share in Value by Region (2024-2029)

Table 93. Latin America Immunology Drug Sales by Country (2018-2023) & (K Units)

Table 94. Latin America Immunology Drug Sales Market Share in Volume by Country (2018-2023)

Table 95. Latin America Immunology Drug Sales by Country (2018-2023) & (US$ Million)

Table 96. Latin America Immunology Drug Sales Market Share in Value by Country (2018-2023)

Table 97. Latin America Immunology Drug Sales by Country (2024-2029) & (K Units)

Table 98. Latin America Immunology Drug Sales Market Share in Volume by Country (2024-2029)

Table 99. Latin America Immunology Drug Sales by Country (2024-2029) & (US$ Million)

Table 100. Latin America Immunology Drug Sales Market Share in Value by Country (2024-2029)

Table 101. Middle East and Africa Immunology Drug Sales by Country (2018-2023) & (K Units)

Table 102. Middle East and Africa Immunology Drug Sales Market Share in Volume by Country (2018-2023)

Table 103. Middle East and Africa Immunology Drug Sales by Country (2018-2023) & (US$ Million)

Table 104. Middle East and Africa Immunology Drug Sales Market Share in Value by Country (2018-2023)

Table 105. Middle East and Africa Immunology Drug Sales by Country (2024-2029) & (K Units)

Table 106. Middle East and Africa Immunology Drug Sales Market Share in Volume by Country (2024-2029)

Table 107. Middle East and Africa Immunology Drug Sales by Country (2024-2029) & (US$ Million)

Table 108. Middle East and Africa Immunology Drug Sales Market Share in Value by Country (2024-2029)

Table 109. Abbott Laboratories Company Information

Table 110. Abbott Laboratories Introduction and Business Overview

Table 111. Abbott Laboratories Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 112. Abbott Laboratories Immunology Drug Product

Table 113. Abbott Laboratories Recent Development

Table 114. Active Biotech Company Information

Table 115. Active Biotech Introduction and Business Overview

Table 116. Active Biotech Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 117. Active Biotech Immunology Drug Product

Table 118. Active Biotech Recent Development

Table 119. Eli Lilly and Company Company Information

Table 120. Eli Lilly and Company Introduction and Business Overview

Table 121. Eli Lilly and Company Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 122. Eli Lilly and Company Immunology Drug Product

Table 123. Eli Lilly and Company Recent Development

Table 124. Autoimmune Inc. Company Information

Table 125. Autoimmune Inc. Introduction and Business Overview

Table 126. Autoimmune Inc. Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 127. Autoimmune Inc. Immunology Drug Product

Table 128. Autoimmune Inc. Recent Development

Table 129. Pfizer Company Information

Table 130. Pfizer Introduction and Business Overview

Table 131. Pfizer Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 132. Pfizer Immunology Drug Product

Table 133. Pfizer Recent Development

Table 134. GlaxoSmithKline plc Company Information

Table 135. GlaxoSmithKline plc Introduction and Business Overview

Table 136. GlaxoSmithKline plc Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 137. GlaxoSmithKline plc Immunology Drug Product

Table 138. GlaxoSmithKline plc Recent Development

Table 139. Seattle Genetics Company Information

Table 140. Seattle Genetics Introduction and Business Overview

Table 141. Seattle Genetics Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 142. Seattle Genetics Immunology Drug Product

Table 143. Seattle Genetics Recent Development

Table 144. Genentech Company Information

Table 145. Genentech Introduction and Business Overview

Table 146. Genentech Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 147. Genentech Immunology Drug Product

Table 148. Genentech Recent Development

Table 149. F. Hoffmann-La Roche Ltd. Company Information

Table 150. F. Hoffmann-La Roche Ltd. Introduction and Business Overview

Table 151. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 152. F. Hoffmann-La Roche Ltd. Immunology Drug Product

Table 153. F. Hoffmann-La Roche Ltd. Recent Development

Table 154. Eisai Co. Company Information

Table 155. Eisai Co. Introduction and Business Overview

Table 156. Eisai Co. Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 157. Eisai Co. Immunology Drug Product

Table 158. Eisai Co. Recent Development

Table 159. Bayer AG Company Information

Table 160. Bayer AG Introduction and Business Overview

Table 161. Bayer AG Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 162. Bayer AG Immunology Drug Product

Table 163. Bayer AG Recent Development

Table 164. Sanofi Aventis LLC. Company Information

Table 165. Sanofi Aventis LLC. Introduction and Business Overview

Table 166. Sanofi Aventis LLC. Immunology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 167. Sanofi Aventis LLC. Immunology Drug Product

Table 168. Sanofi Aventis LLC. Recent Development

Table 169. Key Raw Materials Lists

Table 170. Raw Materials Key Suppliers Lists

Table 171. Immunology Drug Market Trends

Table 172. Immunology Drug Market Drivers

Table 173. Immunology Drug Market Challenges

Table 174. Immunology Drug Market Restraints

Table 175. Immunology Drug Distributors List

Table 176. Immunology Drug Downstream Customers

Table 177. Research Programs/Design for This Report

Table 178. Key Data Information from Secondary Sources

Table 179. Key Data Information from Primary Sources

List of Figures

Figure 1. Immunology Drug Product Picture

Figure 2. Global Immunology Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Immunology Drug Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Immunology Drug Sales Status and Outlook (2018-2029) & (K Units)

Figure 5. Product Picture of Monoclonal Antibodies (mAb)

Figure 6. Global Monoclonal Antibodies (mAb) Sales YoY Growth (2018-2029) & (K Units)

Figure 7. Product Picture of Antibody Drug Conjugates

Figure 8. Global Antibody Drug Conjugates Sales YoY Growth (2018-2029) & (K Units)

Figure 9. Product Picture of Immunosuppressive medication

Figure 10. Global Immunosuppressive medication Sales YoY Growth (2018-2029) & (K Units)

Figure 11. Product Picture of Others

Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)

Figure 13. Global Immunology Drug Sales by Type (2018-2029) & (US$ Million)

Figure 14. Global Immunology Drug Sales Market Share by Type in 2022 & 2029

Figure 15. North America Immunology Drug Sales Market Share in Volume by Type in 2022

Figure 16. North America Immunology Drug Sales Market Share in Value by Type in 2022

Figure 17. Europe Immunology Drug Sales Market Share in Volume by Type in 2022

Figure 18. Europe Immunology Drug Sales Market Share in Value by Type in 2022

Figure 19. Asia-Pacific Immunology Drug Sales Market Share in Volume by Type in 2022

Figure 20. Asia-Pacific Immunology Drug Sales Market Share in Value by Type in 2022

Figure 21. Latin America Immunology Drug Sales Market Share in Volume by Type in 2022

Figure 22. Latin America Immunology Drug Sales Market Share in Value by Type in 2022

Figure 23. Middle East and Africa Immunology Drug Sales Market Share in Volume by Type in 2022

Figure 24. Middle East and Africa Immunology Drug Sales Market Share in Value by Type in 2022

Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Immunology Drug Sales in 2022

Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Immunology Drug Revenue in 2022

Figure 27. Immunology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 28. Product Picture of Hospitals

Figure 29. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)

Figure 30. Product Picture of Clinics

Figure 31. Global Clinics Sales YoY Growth (2018-2029) & (K Units)

Figure 32. Product Picture of Cancer Research Centers and Institutes

Figure 33. Global Cancer Research Centers and Institutes Sales YoY Growth (2018-2029) & (K Units)

Figure 34. Global Immunology Drug Sales by Application (2018-2029) & (US$ Million)

Figure 35. Global Immunology Drug Sales Market Share by Application in 2022 & 2029

Figure 36. North America Immunology Drug Sales Market Share in Volume by Application in 2022

Figure 37. North America Immunology Drug Sales Market Share in Value by Application in 2022

Figure 38. Europe Immunology Drug Sales Market Share in Volume by Application in 2022

Figure 39. Europe Immunology Drug Sales Market Share in Value by Application in 2022

Figure 40. Asia-Pacific Immunology Drug Sales Market Share in Volume by Application in 2022

Figure 41. Asia-Pacific Immunology Drug Sales Market Share in Value by Application in 2022

Figure 42. Latin America Immunology Drug Sales Market Share in Volume by Application in 2022

Figure 43. Latin America Immunology Drug Sales Market Share in Value by Application in 2022

Figure 44. Middle East and Africa Immunology Drug Sales Market Share in Value by Application in 2022

Figure 45. Key Raw Materials Price

Figure 46. Immunology Drug Manufacturing Cost Structure

Figure 47. Immunology Drug Industrial Chain Analysis

Figure 48. Channels of Distribution

Figure 49. Distributors Profiles

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions